Molina Healthcare (MOH) Given New $85.00 Price Target at BMO Capital Markets

Molina Healthcare (NYSE:MOH) had its target price lowered by analysts at BMO Capital Markets from $98.00 to $85.00 in a research report issued to clients and investors on Wednesday. The firm currently has a “market perform” rating on the stock. BMO Capital Markets’ price target points to a potential upside of 15.02% from the stock’s current price.

Other equities analysts have also recently issued research reports about the stock. ValuEngine upgraded shares of Molina Healthcare from a “hold” rating to a “buy” rating in a research report on Thursday, November 9th. Zacks Investment Research cut shares of Molina Healthcare from a “strong-buy” rating to a “hold” rating in a research report on Friday, February 9th. Jefferies Group boosted their price objective on shares of Molina Healthcare from $64.00 to $74.00 and gave the company a “hold” rating in a research report on Friday, November 3rd. Raymond James Financial restated a “hold” rating on shares of Molina Healthcare in a research report on Friday, December 8th. Finally, Goldman Sachs Group started coverage on shares of Molina Healthcare in a research report on Wednesday, January 3rd. They set a “neutral” rating and a $83.00 price target on the stock. Three research analysts have rated the stock with a sell rating, eleven have given a hold rating and four have given a buy rating to the company. The stock presently has a consensus rating of “Hold” and an average target price of $72.50.

Molina Healthcare (MOH) traded down $1.56 during mid-day trading on Wednesday, hitting $73.90. 212,045 shares of the company’s stock were exchanged, compared to its average volume of 1,421,474. Molina Healthcare has a 12-month low of $42.56 and a 12-month high of $93.98. The stock has a market capitalization of $4,250.00, a PE ratio of -9.21, a price-to-earnings-growth ratio of 0.91 and a beta of 1.10. The company has a debt-to-equity ratio of 1.06, a current ratio of 1.29 and a quick ratio of 1.29.

In related news, Director Garrey Carruthers sold 1,300 shares of the business’s stock in a transaction dated Thursday, November 16th. The shares were sold at an average price of $75.66, for a total transaction of $98,358.00. Following the transaction, the director now owns 7,016 shares in the company, valued at $530,830.56. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, Director J Mario Md Molina sold 15,000 shares of the business’s stock in a transaction dated Monday, December 4th. The shares were sold at an average price of $78.52, for a total transaction of $1,177,800.00. The disclosure for this sale can be found here. Insiders have sold 703,705 shares of company stock worth $56,003,375 in the last quarter. 6.20% of the stock is owned by corporate insiders.

A number of institutional investors and hedge funds have recently made changes to their positions in MOH. Iridian Asset Management LLC CT purchased a new stake in Molina Healthcare in the fourth quarter worth about $128,179,000. Renaissance Technologies LLC grew its holdings in Molina Healthcare by 53.5% in the fourth quarter. Renaissance Technologies LLC now owns 2,156,150 shares of the company’s stock worth $165,334,000 after purchasing an additional 751,800 shares during the period. Jana Partners LLC grew its holdings in Molina Healthcare by 52.5% in the third quarter. Jana Partners LLC now owns 2,125,351 shares of the company’s stock worth $146,139,000 after purchasing an additional 731,992 shares during the period. Tavio Capital LLC grew its holdings in Molina Healthcare by 418.0% in the third quarter. Tavio Capital LLC now owns 537,192 shares of the company’s stock worth $36,937,000 after purchasing an additional 433,485 shares during the period. Finally, Victory Capital Management Inc. grew its holdings in Molina Healthcare by 36.0% in the fourth quarter. Victory Capital Management Inc. now owns 1,590,409 shares of the company’s stock worth $121,953,000 after purchasing an additional 420,756 shares during the period. Institutional investors and hedge funds own 96.22% of the company’s stock.

ILLEGAL ACTIVITY NOTICE: This news story was reported by American Banking News and is owned by of American Banking News. If you are viewing this news story on another domain, it was copied illegally and republished in violation of international copyright and trademark legislation. The legal version of this news story can be read at https://www.americanbankingnews.com/2018/02/14/molina-healthcare-moh-given-new-85-00-price-target-at-bmo-capital-markets.html.

About Molina Healthcare

Molina Healthcare, Inc offers Medicaid-related solutions for low-income families and individuals, and assists government agencies in their administration of the Medicaid program. The Company operates through three segments: Health Plans, Molina Medicaid Solutions and Other, which includes its Pathways Health and Community Support LLC (Pathways) business.

Analyst Recommendations for Molina Healthcare (NYSE:MOH)

Receive News & Ratings for Molina Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Molina Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply